Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | MMP3 | P08254 | 1/20 | 0.32 |
| ▸ | MMP9 | P14780 | 1/20 | 0.32 |
| ▸ | MMP13 | P45452 | 1/20 | 0.32 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.32 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL731592 | 0.81 | TSHR (0.38) | TP53CYP1A2GAACYP2C9PKM | |
| Acetic Acid SCHEMBL8512781 | 0.79 | TSHR (0.36) | TP53CYP1A2GAACYP2C9PKM | |
| SCHEMBL21194066 | 0.79 | TSHR (0.36) | TP53CYP1A2GAACYP2C9PKM | |
| SCHEMBL526912 | 0.77 | TSHR (0.45) | TP53CYP1A2GAACYP2C9PKM | |
| SCHEMBL9842552 | 0.77 | TSHR (0.45) | TP53CYP1A2GAACYP2C9PKM | |
| SCHEMBL890983 | 0.77 | — | — | |
| SCHEMBL21173640 | 0.77 | TP53 (0.42) | TP53CYP1A2GAACYP2C9PKM | |
| SCHEMBL13911750 | 0.77 | — | — | |
| SCHEMBL1778617 | 0.77 | — | — | |
| Ammonia Solution, Strong SCHEMBL18138980 | 0.75 | TSHR (0.43) | TP53TDP1TSHRSLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4237611-A1 | BINDER COMPOSITIONS | OrganoClick AB (SE) | 2023-09-06 | — | — | EP | disclosed |
| US-20230139056-A1 | METHODS, COMPOSITIONS AND REAGENTS FOR PREPARING COMPOUNDS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2023-05-04 | — | — | US | disclosed |
| WO-2022139670-A1 | BINDER COMPOSITIONS | ORGANOCLICK AB (SE) | 2022-06-30 | — | — | WO | disclosed |
| US-20140158942-A1 | WATER-GAS SHIFT CATALYST | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2014-06-12 | — | — | US | disclosed |
| WO-2012168690-A1 | WATER-GAS SHIFT CATALYST | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2012-12-13 | — | — | WO | disclosed |
| EP-0375658-B1 | Quinoline derivatives and processes for preparation thereof | DAINIPPON PHARMACEUTICAL CO (JP) | 1994-08-03 | — | — | EP | disclosed |
| EP-0312085-B1 | NOVEL QUINOLINE DERIVATIVES, PROCESSES FOR PREPARATION THEREOF AND ANTIBACTERIAL AGENT CONTAINING THEM | Dainippon Pharmaceutical Co., Ltd. (JP) | 1993-05-12 | — | — | EP | disclosed |
| US-5164392-A | Active against streptococci and staphylococci | DAINIPPON PHARMACEUTICAL CO., LTD. (JP) | 1992-11-17 | — | — | US | disclosed |
| US-5013841-A | Oxo quinoline derivatives | DAINIPPON PHARMACEUTICAL CO., LTD. (JP) | 1991-05-07 | — | — | US | disclosed |
| EP-0375658-A1 | Quinoline derivatives and processes for preparation thereof | Dainippon Pharmaceutical Co., Ltd. (JP) | 1990-06-27 | — | — | EP | disclosed |
| EP-0312085-A2 | Novel quinoline derivatives, processes for preparation thereof and antibacterial agent containing them | Dainippon Pharmaceutical Co., Ltd. (JP) | 1989-04-19 | — | — | EP | disclosed |
| EP-0221463-A2 | Quinoline derivatives and processes for preparation thereof | Dainippon Pharmaceutical Co., Ltd. (JP) | 1987-05-13 | — | — | EP | disclosed |